First Trimester Iron Status and Obstetric and Perinatal Outcomes

Research output: Working paperPreprintResearch

Standard

First Trimester Iron Status and Obstetric and Perinatal Outcomes. / Hansen, Rebecka; Spangmose, Anne Lærke; Sommer, Veronika Markova; Holm, Charlotte; Jørgensen, Finn Stener; Krebs, Lone; Pinborg, Anja.

Research Square, 2021.

Research output: Working paperPreprintResearch

Harvard

Hansen, R, Spangmose, AL, Sommer, VM, Holm, C, Jørgensen, FS, Krebs, L & Pinborg, A 2021 'First Trimester Iron Status and Obstetric and Perinatal Outcomes' Research Square. https://doi.org/10.21203/rs.3.rs-1048128/v1

APA

Hansen, R., Spangmose, A. L., Sommer, V. M., Holm, C., Jørgensen, F. S., Krebs, L., & Pinborg, A. (2021). First Trimester Iron Status and Obstetric and Perinatal Outcomes. Research Square. https://doi.org/10.21203/rs.3.rs-1048128/v1

Vancouver

Hansen R, Spangmose AL, Sommer VM, Holm C, Jørgensen FS, Krebs L et al. First Trimester Iron Status and Obstetric and Perinatal Outcomes. Research Square. 2021. https://doi.org/10.21203/rs.3.rs-1048128/v1

Author

Hansen, Rebecka ; Spangmose, Anne Lærke ; Sommer, Veronika Markova ; Holm, Charlotte ; Jørgensen, Finn Stener ; Krebs, Lone ; Pinborg, Anja. / First Trimester Iron Status and Obstetric and Perinatal Outcomes. Research Square, 2021.

Bibtex

@techreport{987e4ba4ccf24f85877200112fb1b492,
title = "First Trimester Iron Status and Obstetric and Perinatal Outcomes",
abstract = "Purpose: To assess the following in singleton pregnant women: 1) associations between first trimester iron deficiency and obstetric and perinatal outcomes, 2) overall first trimester iron status and 3) post-treatment iron status after intensified iron supplementation.Methods: Prospective cohort study with linkage of first trimester hemoglobin and plasma ferritin with obstetric and perinatal data from a hospital database. Blood sample data were obtained at a Danish University Hospital. The cohort was divided into groups according to ferritin and hemoglobin: (1) iron deficient anemic (ferritin <30 ng/mL and Hb <110 g/L), (2) iron deficient non-anemic (ferritin <30 ng/mL and Hb ≥110 g/L), and (3) iron replete non-anemic (ferritin 30–200 ng/mL and Hb ≥110 g/L). Obstetric and perinatal outcomes in each iron deficient group were compared to the iron replete non-anemic group using multivariable logistic regression. The effect of 2–8 weeks intensified iron supplementation on hemoglobin and ferritin were assessed by pairwise comparisons.Results: The cohort comprised 5,763 singleton pregnant women, of which 14.2% had non-anemic iron deficiency, and 1.2% had iron deficiency anemia. Compared to iron replete non-anemic women, iron deficient anemic women had a higher risk of gestational diabetes (aOR 3.8, 95% CI 1.4–9.0), and iron deficient non-anemic women had a higher risk of stillbirth (aOR 4.0, 95% CI 1.0–14.3). In group 1 and 2, 78.7% and 67.8% remained iron deficient after intensified iron supplementation.Conclusion: First trimester iron deficiency may be associated with gestational diabetes and stillbirth. First trimester iron deficiency was present in 15.4% and often persisted despite 2–8 weeks intensified iron supplementation.",
author = "Rebecka Hansen and Spangmose, {Anne L{\ae}rke} and Sommer, {Veronika Markova} and Charlotte Holm and J{\o}rgensen, {Finn Stener} and Lone Krebs and Anja Pinborg",
year = "2021",
doi = "10.21203/rs.3.rs-1048128/v1",
language = "English",
publisher = "Research Square",
type = "WorkingPaper",
institution = "Research Square",

}

RIS

TY - UNPB

T1 - First Trimester Iron Status and Obstetric and Perinatal Outcomes

AU - Hansen, Rebecka

AU - Spangmose, Anne Lærke

AU - Sommer, Veronika Markova

AU - Holm, Charlotte

AU - Jørgensen, Finn Stener

AU - Krebs, Lone

AU - Pinborg, Anja

PY - 2021

Y1 - 2021

N2 - Purpose: To assess the following in singleton pregnant women: 1) associations between first trimester iron deficiency and obstetric and perinatal outcomes, 2) overall first trimester iron status and 3) post-treatment iron status after intensified iron supplementation.Methods: Prospective cohort study with linkage of first trimester hemoglobin and plasma ferritin with obstetric and perinatal data from a hospital database. Blood sample data were obtained at a Danish University Hospital. The cohort was divided into groups according to ferritin and hemoglobin: (1) iron deficient anemic (ferritin <30 ng/mL and Hb <110 g/L), (2) iron deficient non-anemic (ferritin <30 ng/mL and Hb ≥110 g/L), and (3) iron replete non-anemic (ferritin 30–200 ng/mL and Hb ≥110 g/L). Obstetric and perinatal outcomes in each iron deficient group were compared to the iron replete non-anemic group using multivariable logistic regression. The effect of 2–8 weeks intensified iron supplementation on hemoglobin and ferritin were assessed by pairwise comparisons.Results: The cohort comprised 5,763 singleton pregnant women, of which 14.2% had non-anemic iron deficiency, and 1.2% had iron deficiency anemia. Compared to iron replete non-anemic women, iron deficient anemic women had a higher risk of gestational diabetes (aOR 3.8, 95% CI 1.4–9.0), and iron deficient non-anemic women had a higher risk of stillbirth (aOR 4.0, 95% CI 1.0–14.3). In group 1 and 2, 78.7% and 67.8% remained iron deficient after intensified iron supplementation.Conclusion: First trimester iron deficiency may be associated with gestational diabetes and stillbirth. First trimester iron deficiency was present in 15.4% and often persisted despite 2–8 weeks intensified iron supplementation.

AB - Purpose: To assess the following in singleton pregnant women: 1) associations between first trimester iron deficiency and obstetric and perinatal outcomes, 2) overall first trimester iron status and 3) post-treatment iron status after intensified iron supplementation.Methods: Prospective cohort study with linkage of first trimester hemoglobin and plasma ferritin with obstetric and perinatal data from a hospital database. Blood sample data were obtained at a Danish University Hospital. The cohort was divided into groups according to ferritin and hemoglobin: (1) iron deficient anemic (ferritin <30 ng/mL and Hb <110 g/L), (2) iron deficient non-anemic (ferritin <30 ng/mL and Hb ≥110 g/L), and (3) iron replete non-anemic (ferritin 30–200 ng/mL and Hb ≥110 g/L). Obstetric and perinatal outcomes in each iron deficient group were compared to the iron replete non-anemic group using multivariable logistic regression. The effect of 2–8 weeks intensified iron supplementation on hemoglobin and ferritin were assessed by pairwise comparisons.Results: The cohort comprised 5,763 singleton pregnant women, of which 14.2% had non-anemic iron deficiency, and 1.2% had iron deficiency anemia. Compared to iron replete non-anemic women, iron deficient anemic women had a higher risk of gestational diabetes (aOR 3.8, 95% CI 1.4–9.0), and iron deficient non-anemic women had a higher risk of stillbirth (aOR 4.0, 95% CI 1.0–14.3). In group 1 and 2, 78.7% and 67.8% remained iron deficient after intensified iron supplementation.Conclusion: First trimester iron deficiency may be associated with gestational diabetes and stillbirth. First trimester iron deficiency was present in 15.4% and often persisted despite 2–8 weeks intensified iron supplementation.

U2 - 10.21203/rs.3.rs-1048128/v1

DO - 10.21203/rs.3.rs-1048128/v1

M3 - Preprint

BT - First Trimester Iron Status and Obstetric and Perinatal Outcomes

PB - Research Square

ER -

ID: 305185909